309 related articles for article (PubMed ID: 10064603)
21. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
[TBL] [Abstract][Full Text] [Related]
22. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Bohne J; Kräusslich HG
FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
[TBL] [Abstract][Full Text] [Related]
23. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex.
Liu Y; Suñé C; Garcia-Blanco MA
Virology; 1999 Mar; 255(2):337-46. PubMed ID: 10069959
[TBL] [Abstract][Full Text] [Related]
25. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
Chipitsyna G; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
[TBL] [Abstract][Full Text] [Related]
26. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
28. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
29. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
30. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
Wright S; Luccarini C
J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
Dreikhausen U; Hiebenthal-Millow K; Bartels M; Resch K; Nourbakhsh M
Mol Cell Biol; 2005 Sep; 25(17):7473-83. PubMed ID: 16107696
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
34. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
[TBL] [Abstract][Full Text] [Related]
35. Cyclin K/CPR4 inhibits primate lentiviral replication by inactivating Tat/positive transcription elongation factor b-dependent long terminal repeat transcription.
Urano E; Shimizu S; Futahashi Y; Hamatake M; Morikawa Y; Takahashi N; Fukazawa H; Yamamoto N; Komano J
AIDS; 2008 May; 22(9):1081-3. PubMed ID: 18520353
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.
Raha T; Cheng SW; Green MR
PLoS Biol; 2005 Feb; 3(2):e44. PubMed ID: 15719058
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
[TBL] [Abstract][Full Text] [Related]
39. Tat mediates transcriptional activation of HIV-1 gene in vitro.
West M; Hoover T; Kung H; Raziuddin
Indian J Biochem Biophys; 1995 Dec; 32(6):351-5. PubMed ID: 8714203
[TBL] [Abstract][Full Text] [Related]
40. Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
Verhoef K; Klein A; Berkhout B
Virology; 1996 Nov; 225(2):316-27. PubMed ID: 8918918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
